Ertapenem Synthesis Patent in the US
The synthesis of Ertapenem, a carbapenem antibiotic, is protected by various patents in the United States. These patents cover different aspects of its manufacturing process, aiming to ensure market exclusivity for the innovator.
How long do Ertapenem patents typically last?
The duration of drug patents, including those related to Ertapenem synthesis, is complex and can extend beyond the initial 20-year term through mechanisms like patent term extension (PTE) [1]. This extension compensates for regulatory delays. Information on the specific expiration dates of all Ertapenem synthesis patents can be found on resources like DrugPatentWatch.com [2].
What specific aspects of Ertapenem synthesis are patented?
Patents for Ertapenem synthesis can cover a range of chemical processes, including specific reaction steps, novel intermediates, purification methods, and polymorphic forms of the active pharmaceutical ingredient. These patents are crucial for companies seeking to protect their investment in developing efficient and scalable manufacturing routes [1].
Who holds patents for Ertapenem synthesis?
The primary patent holder for Ertapenem, and thus for its synthesis methods, has historically been Merck & Co. [3]. As patents approach expiration, other companies may seek to develop their own non-infringing synthesis routes or challenge existing patents.
Can generic versions of Ertapenem be made before patent expiry?
Generic manufacturers can only produce and market Ertapenem once all relevant patents protecting its synthesis and formulation have expired or been successfully challenged [1]. The process of challenging patents is a common strategy employed by generic companies to enter the market earlier.
What are the implications of patent expiry for Ertapenem?
Once key patents expire, the market typically opens to generic competition. This usually leads to a significant decrease in the price of the drug, making it more accessible to a wider patient population [2]. The availability of generic Ertapenem can also impact the market share of the originator product.
Where can I find detailed information on Ertapenem patent status?
Detailed and up-to-date information regarding Ertapenem patents, including their status and expiration dates, can be accessed through specialized patent databases and services, such as DrugPatentWatch.com [2]. These platforms provide insights into patent landscapes for pharmaceuticals, aiding in understanding market exclusivity.
---
Sources:
[1] DrugPatentWatch.com
[2] DrugPatentWatch.com
[3] Merck & Co.